Mersana Therapeutics | DEF 14A: Definitive information statements
Mersana Therapeutics | DEFA14A: Others
Mersana Therapeutics | 8-K: Current report
Mersana Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Mersana Therapeutics | 8-K: Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results
Mersana Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mersana Therapeutics | 8-K: Current report
Mersana Therapeutics | 8-K: Current report
Mersana Therapeutics | 8-K: Mersana Therapeutics Provides Business Update and Announces Third Quarter 2023 Financial Results
Mersana Therapeutics | 8-K: Current report
Mersana Therapeutics | 8-K: Current report
Mersana Therapeutics | 8-K: Current report
Mersana Therapeutics | 8-K: Mersana Therapeutics Announces Second Quarter 2023 Financial Results
Mersana Therapeutics | 8-K: Current report
Mersana Therapeutics | 8-K: Current report
Mersana Therapeutics | 8-K: Current report
Mersana Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Mersana Therapeutics | 8-K: Mersana Therapeutics Provides Business Update and Announces First Quarter 2023 Financial Results
Mersana Therapeutics | DEFA14A: Others
Mersana Therapeutics | DEF 14A: Definitive proxy statements
No Data